Sahani 2006.
Study characteristics | |||
Patient sampling | Type of study: retrospective study. Consecutive or random sample: unclear. | ||
Patient characteristics and setting | Sample size: 25. Females: 12 (48.0%). Age: 69 years. Presentation: Patients with IPMN undergoing surgery. Setting: secondary care, USA. | ||
Index tests | Index test: CT.
Further details:
Technical specifications: LightSpeed QX/I (GE Medical Systems).
Performed by: radiologist.
Criteria for positive diagnosis: presence of mural nodules, papillary projections, or a solid mass in the dilated duct or within the cystic lesion. Index test: MRI. Further details: Technical specifications: 1.5‐T system Signa (GE Medical Systems). Performed by: radiologist. Criteria for positive diagnosis: presence of mural nodules, papillary projections, or a solid mass in the dilated duct or within the cystic lesion. |
||
Target condition and reference standard(s) | Target condition: precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia). Reference standard: surgical excision. Further details: Technical specifications: not applicable. Performed by: clinicians. Criteria for positive diagnosis: not stated. | ||
Flow and timing | Number of indeterminates for whom the results of reference standard were available: not stated. Number of patients who were excluded from the analysis: not stated. | ||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Unclear | High | ||
DOMAIN 2: Index Test Precancerous or cancerous (intermediate or high grade dysplasia or invasive carcinoma) versus precancerous (low grade dysplasia) ‐ CT | |||
If a threshold was used, was it pre‐specified? | No | ||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
High | Low | ||
DOMAIN 2: Index Test Precancerous or cancerous (intermediate or high grade dysplasia or invasive carcinoma) versus precancerous (low grade dysplasia) ‐ MRI | |||
If a threshold was used, was it pre‐specified? | No | ||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
High | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Unclear | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Unclear | ||
Unclear |